Open AccessMyocardial Revascularization in COVID-19 Era
Author(s) -
Sasmojo Widito
Publication year - 2021
Publication title -
heart science journal
Language(s) - English
Resource type - Journals
eISSN - 2721-9984
pISSN - 2721-9976
DOI - 10.21776/ub.hsj.2021.002.03.1
Subject(s) - covid-19 , medicine , pandemic , acute coronary syndrome , revascularization , intensive care medicine , disease , cardiac catheterization , cardiology , virology , myocardial infarction , infectious disease (medical specialty) , outbreak
Coronavirus disease 2019 (COVID-19) is a highly contagious disease caused by the coronavirus 2 that causes severe acute respiratory syndrome (SARS-CoV-2). More discussion is required to achieve the balance between clinical benefit and risk in the treatment of acute coronary syndrome (ACS) patients with COVID-19. The current COVID-19 pandemic prompts the need to evaluate criteria for indication and efficacy of the general safety protocols and particular cardiac catheterization laboratory (CCL) procedures to safeguard the patient and healthcare professionals
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom